92 related articles for article (PubMed ID: 1680639)
1. Metabolism of the acyl-CoA:cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide in rat and monkey. Omega-/beta-oxidation pathway.
Woolf TF; Bjorge SM; Black AE; Holmes A; Chang T
Drug Metab Dispos; 1991; 19(3):696-702. PubMed ID: 1680639
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo disposition of 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide (CI-976). Identification of a novel five-carbon cleavage metabolite in rats.
Sinz MW; Black AE; Bjorge SM; Holmes A; Trivedi BK; Woolf TF
Drug Metab Dispos; 1997 Jan; 25(1):123-30. PubMed ID: 9010639
[TBL] [Abstract][Full Text] [Related]
3. Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
Woolf TF; Black A; Shum YY; McNally W; Lee H; Chang T
Drug Metab Dispos; 1993; 21(6):1112-8. PubMed ID: 7905392
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of nimodipine in rat, dog, and monkey.
Scherling D; Bühner K; Krause HP; Karl W; Wünsche C
Arzneimittelforschung; 1991 Apr; 41(4):392-8. PubMed ID: 1859512
[TBL] [Abstract][Full Text] [Related]
6. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
Burrier RE; Smith AA; McGregor DG; Hoos LM; Zilli DL; Davis HR
J Pharmacol Exp Ther; 1995 Jan; 272(1):156-63. PubMed ID: 7815329
[TBL] [Abstract][Full Text] [Related]
7. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
8. Determination of 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl) dodecanamide, CI-976, in rat plasma by reversed-phase high-performance liquid chromatography.
Shum YY; Black A; Chang T
J Chromatogr B Biomed Appl; 1994 Mar; 653(2):205-9. PubMed ID: 8205247
[TBL] [Abstract][Full Text] [Related]
9. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
Cheng H; Stuhler JD; Dorrbecker BR; Gordon WP
Drug Metab Dispos; 1991; 19(1):212-7. PubMed ID: 1673401
[TBL] [Abstract][Full Text] [Related]
11. Metabolic disposition of isoxicam in man, monkey, dog, and rat.
Borondy PE; Michniewicz BM
Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211
[TBL] [Abstract][Full Text] [Related]
12. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
[TBL] [Abstract][Full Text] [Related]
13. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys.
Whitaker NG; Lindstrom TD
Drug Metab Dispos; 1987; 15(1):107-13. PubMed ID: 2881745
[TBL] [Abstract][Full Text] [Related]
14. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
Emary WB; Toren PC; Mathews B; Huh K
Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
17. The metabolism of [14C]rimantadine hydrochloride in rats and dogs.
Loh AC; Szuna AJ; Williams TH; Sasso GJ; Leinweber FJ
Drug Metab Dispos; 1991; 19(2):381-7. PubMed ID: 1676641
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
[TBL] [Abstract][Full Text] [Related]
19. The metabolism of [14C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in laboratory animals.
Wilson ID; Watson KV; Troke J; Illing HP; Fromson JM
Xenobiotica; 1986 Dec; 16(12):1117-28. PubMed ID: 3798959
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of citral, an alpha,beta-unsaturated aldehyde, in male F344 rats.
Diliberto JJ; Srinivas P; Overstreet D; Usha G; Burka LT; Birnbaum LS
Drug Metab Dispos; 1990; 18(6):866-75. PubMed ID: 1981530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
